{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:21:02Z","timestamp":1790256062034,"version":"4.1.0"},"reference-count":62,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,5,8]]},"DOI":"10.3233\/jad-171181","type":"journal-article","created":{"date-parts":[[2018,4,29]],"date-time":"2018-04-29T11:37:21Z","timestamp":1525001841000},"page":"887-897","source":"Crossref","is-referenced-by-count":26,"title":["Rapidly Progressive Alzheimer\u2019s Disease: Contributions to Clinical-Pathological Definition and Diagnosis"],"prefix":"10.1177","volume":"63","author":[{"given":"Samir","family":"Abu-Rumeileh","sequence":"first","affiliation":[{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Capellari","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy"},{"name":"IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[{"name":"IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy"},{"name":"Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-171181_ref1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.3233\/JAD-171181_ref2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000278692","article-title":"Clinical features of rapidly progressive Alzheimer\u2019s disease","volume":"29","author":"Schmidt","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-171181_ref3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archneurol.2011.189","article-title":"Rapidly progressive Alzheimer disease","volume":"68","author":"Schmidt","year":"2011","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-171181_ref4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.22454","article-title":"Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease","volume":"70","author":"Chitravas","year":"2011","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-171181_ref5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JAD-2012-120007","article-title":"Rapidly progressive Alzheimer\u2019s disease: A multicenter update","volume":"30","author":"Schmidt","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-171181_ref6","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/brain\/awv006","article-title":"Rapidly progressive Alzheimer\u2019s disease features distinct structures of amyloid-\u03b2","volume":"138","author":"Cohen","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-171181_ref7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jamaneurol.2014.4068","article-title":"Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease","volume":"72","author":"Dorey","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-171181_ref8","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3233\/JAD-160740","article-title":"Diagnostic accuracy of a combined analysis of cerebrospinal fluid t-PrP, t-tau, p-tau, and A\u03b242 in the differential diagnosis of Creutzfeldt-Jakob Disease from Alzheimer\u2019s disease with emphasis on atypical disease variants","volume":"55","author":"Abu Rumeileh","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-171181_ref9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13195-017-0331-1","article-title":"The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias","volume":"10","author":"Abu-Rumeileh","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-171181_ref10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00401-017-1691-0","article-title":"Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer\u2019s disease","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-171181_ref11","doi-asserted-by":"crossref","first-page":"e36333","DOI":"10.1371\/journal.pone.0036333","article-title":"Human prion diseases in the Netherlands (1998-2009): Clinical, genetic and molecular aspects","volume":"7","author":"Jansen","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-171181_ref12","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/brain\/aws238","article-title":"Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: A longitudinal multicentre study over 10 years","volume":"135","author":"Stoeck","year":"2012","journal-title":"Brain"},{"key":"10.3233\/JAD-171181_ref13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00401-017-1683-0","article-title":"Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: Aiagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A\u03b242 levels","volume":"133","author":"Lattanzio","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-171181_ref14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF03028618","article-title":"Rapid cognitive decline in Alzheimer\u2019s disease. Consensus paper","volume":"12","author":"Soto","year":"2008","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-171181_ref15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/ane.12415","article-title":"Neuropsychological predictors of rapidly progressive Alzheimer\u2019s disease","volume":"132","author":"Tosto","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-171181_ref16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jalz.2015.10.009","article-title":"Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia","volume":"12","author":"Llorens","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-171181_ref17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.trci.2016.12.005","article-title":"The prevalence and biomarkers\u2019 characteristic of rapidly progressive Alzheimer\u2019s disease from the Alzheimer\u2019s Disease Neuroimaging Initiative database","volume":"3","author":"Ba","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-171181_ref18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jalz.2016.09.013","article-title":"Evaluation of \u03b1-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases","volume":"13","author":"Llorens","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-171181_ref19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fnagi.2017.00289","article-title":"Cerebrospinal fluid biomarkers of Alzheimer\u2019s disease show different but partially overlapping profile compared to vascular dementia","volume":"9","author":"Llorens","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-171181_ref20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-017-0226-4","article-title":"YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias","volume":"12","author":"Llorens","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-171181_ref21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature20814","article-title":"Structural variation in amyloid-\u03b2 fibrils from Alzheimer\u2019s disease clinical subtypes","volume":"541","author":"Qiang","year":"2017","journal-title":"Nature"},{"key":"10.3233\/JAD-171181_ref22","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.62.10.1601","article-title":"Delusions and hallucinations are associated with worse outcome in Alzheimer disease","volume":"62","author":"Scarmeas","year":"2005","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-171181_ref23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S1041610209991001","article-title":"Trajectories of cognitive decline in Alzheimer\u2019s disease","volume":"22","author":"Wilkosz","year":"2010","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-171181_ref24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-171181_ref25","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"10.3233\/JAD-171181_ref26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-171181_ref27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-171181_ref28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.3233\/JAD-171181_ref29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jamaneurol.2013.6455","article-title":"Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: Results from the Swedish Mortality Registry","volume":"71","author":"Skillb\u00e4ck","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-171181_ref30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-171181_ref31","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer\u2019s disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.3233\/JAD-171181_ref32","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.3233\/JAD-171181_ref33","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/jnnp.2009.197962","article-title":"The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: A 10-year review","volume":"81","author":"Chohan","year":"2010","journal-title":"J Neurol Neurosur Psychiatry"},{"key":"10.3233\/JAD-171181_ref34","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1212\/WNL.0b013e3181bd8271","article-title":"CSF biomarkers predict rate of cognitive decline in Alzheimer disease","volume":"73","author":"Kester","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-171181_ref35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/archneurol.2009.55","article-title":"Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type","volume":"66","author":"Snider","year":"2009","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-171181_ref36","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.0b013e3181dd4dd8","article-title":"CSF biomarkers predict a more malignant outcome in Alzheimer disease","volume":"74","author":"Wallin","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-171181_ref37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000355556","article-title":"High tau levels in cerebrospinal fluid predict rapid decline and increased dementia mortality in Alzheimer\u2019s disease","volume":"37","author":"Degerman Gunnarsson","year":"2014","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-171181_ref38","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3233\/JAD-160267","article-title":"Stratification by genetic and demographic characteristics improves diagnostic accuracy of cerebrospinal fluid biomarkers in rapidly progressive dementia","volume":"54","author":"Karch","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-171181_ref39","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.2006.04404.x","article-title":"Amyloid beta peptide ratio 42\/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load","volume":"101","author":"Wiltfang","year":"2007","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-171181_ref40","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/brain\/aww160","article-title":"Pittsburgh compound B imaging and cerebrospinal fluid amyloid-beta in a multicentre European memory clinic study","volume":"139","author":"Leuzy","year":"2016","journal-title":"Brain"},{"key":"10.3233\/JAD-171181_ref41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-160722","article-title":"Cerebrospinal fluid A\u03b242\/40 corresponds better than A\u03b242 to amyloid PET in Alzheimer\u2019s disease","volume":"55","author":"Lewczuk","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-171181_ref42","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-170327","article-title":"The cerebrospinal fluid A\u03b21-42\/A\u03b21-40 ratio improves concordance with amyloid-PET for diagnosing Alzheimer\u2019s disease in a clinical setting","volume":"60","author":"Niemantsverdriet","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-171181_ref43","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3233\/JAD-130107","article-title":"Cerebrospinal fluid Abeta1- 40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels","volume":"36","author":"Slaets","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-171181_ref44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-141986","article-title":"Diagnostic accuracy of cerebrospinal fluid amyloid-beta isoforms for early and differential dementia diagnosis","volume":"45","author":"Struyfs","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-171181_ref45","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00415-004-0311-9","article-title":"Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients","volume":"251","author":"Van Everbroeck","year":"2004","journal-title":"J Neurol"},{"key":"10.3233\/JAD-171181_ref46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies","volume":"3","author":"Fairfoul","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-171181_ref47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-014-0170-y","article-title":"Immune responses in rapidly progressive dementia: A comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer\u2019s disease and multiple sclerosis","volume":"11","author":"Stoeck","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-171181_ref48","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","article-title":"CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival","volume":"83","author":"Skillb\u00e4ck","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-171181_ref49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-171181_ref50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-171181_ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-171181_ref52","doi-asserted-by":"crossref","first-page":"a006262","DOI":"10.1101\/cshperspect.a006262","article-title":"Biochemistry of amyloid \u03b2-protein and amyloid deposits in Alzheimer disease","volume":"2","author":"Masters","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-171181_ref53","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-171181_ref54","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","article-title":"Staging of neurofibrillary pathology in Alzheimer\u2019s disease: A study of the BrainNet Europe Consortium","volume":"18","author":"Alafuzoff","year":"2008","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-171181_ref55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00401-009-0485-4","article-title":"Assessment of beta-amyloid deposits in human brain: A study of the BrainNet Europe Consortium","volume":"117","author":"Alafuzoff","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-171181_ref56","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","article-title":"Cerebral amyloid angiopathy and its relationship to Alzheimer\u2019s disease","volume":"115","author":"Thal","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-171181_ref57","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.410300503","article-title":"Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study","volume":"30","author":"Vonsattel","year":"1991","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-171181_ref58","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/WNL.46.6.1592","article-title":"Cerebral amyloid angiopathy in the brains of patients with Alzheimer\u2019s disease: The CERAD experience, Part XV","volume":"46","author":"Ellis","year":"1996","journal-title":"Neurology"},{"key":"10.3233\/JAD-171181_ref59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00401-010-0779-6","article-title":"Phenotypic variability of sporadic human prion disease and its molecular basis: Past, present, and future","volume":"121","author":"Parchi","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-171181_ref60","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.1105850","article-title":"Self-propagating, molecular-level polymorphism in Alzheimer\u2019s beta-amyloid fibrils","volume":"307","author":"Petkova","year":"2005","journal-title":"Science"},{"key":"10.3233\/JAD-171181_ref61","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12035-016-9694-8","article-title":"Strain-specific altered regulatory response of Rab7a and tau in Creutzfeldt-Jakob Disease and Alzheimer\u2019s disease","volume":"54","author":"Zafar","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-171181_ref62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3233\/JAD-170237","article-title":"Prion protein interactome: Identifying novel targets in slowly and rapidly progressive forms of Alzheimer\u2019s disease","volume":"59","author":"Zafar","year":"2017","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-171181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:00Z","timestamp":1777370820000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-171181"}},"subtitle":[],"editor":[{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":62,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-171181","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]}}}